Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
99,337,748
-
Number of holders
-
10
-
Total 13F shares, excl. options
-
678,173
-
Shares change
-
+6,523
-
Total reported value, excl. options
-
$779,897
-
Value change
-
+$3,467
-
Number of buys
-
3
-
Number of sells
-
2
-
Price
-
$1.15
Institutional Holders of PLUS THERAPEUTICS, INC. - Common Stock, $0.001 par value (PSTV) as of Q4 2024
As of 31 Dec 2024 PLUS THERAPEUTICS, INC. - Common Stock, $0.001 par value (PSTV) had 12 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 678,173 shares of stock of the company.
Largest 10 holders included AIGH Capital Management LLC, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, TWO SIGMA SECURITIES, LLC, BlackRock, Inc., Tower Research Capital LLC (TRC), OSAIC HOLDINGS, INC., SBI Securities Co., Ltd., BANK OF AMERICA CORP /DE/, and GROUP ONE TRADING LLC.
This table shows 12 institutional shareholders of the security as of 31 Dec 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.